RecallHawk

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE

EPIC PHARMA LLC

Summary

FDA approved DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE by EPIC PHARMA LLC. ANDA (Generic) approval (Labeling) on 2023-10-13. TABLET, ORAL.

Details

Source

Drug Approval

External ID

ANDA040444-37

Action Date

2023-10-13

Status

Approved

Category

drug

Product Code

ANDA (Generic)

Product Description

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE, TABLET, ORAL. Application: ANDA040444

Context & Analysis

EPIC PHARMA LLC has 27 FDA actions in our database.

Frequently Asked Questions

How often does EPIC PHARMA LLC have FDA actions?

EPIC PHARMA LLC has 27 FDA actions in our database, including 0 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "ANDA040444-37" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions